These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7520848)

  • 1. The genetic defect of PNH.
    Kinoshita T
    Clin Exp Immunol; 1994 Aug; 97 Suppl 2(Suppl 2):3-4. PubMed ID: 7520848
    [No Abstract]   [Full Text] [Related]  

  • 2. Defective glycosyl phosphatidylinositol anchor synthesis and paroxysmal nocturnal hemoglobinuria.
    Kinoshita T; Inoue N; Takeda J
    Adv Immunol; 1995; 60():57-103. PubMed ID: 8607375
    [No Abstract]   [Full Text] [Related]  

  • 3. Membrane inhibitor of reactive lysis.
    Holguin MH; Parker CJ
    Curr Top Microbiol Immunol; 1992; 178():61-85. PubMed ID: 1385046
    [No Abstract]   [Full Text] [Related]  

  • 4. GPI-linked molecules on lymphoid cells of allogeneic BMT patients.
    Pálóczi K; Mihalik R; Reményi P; Milosevits J; Petrányi GG; Demeter J
    Immunol Today; 1995 Jun; 16(6):302-4. PubMed ID: 7544979
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
    Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxysmal nocturnal hemoglobinuria in children.
    van den Heuvel-Eibrink MM
    Paediatr Drugs; 2007; 9(1):11-6. PubMed ID: 17291133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement.
    Parker CJ
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):36-42. PubMed ID: 1718642
    [No Abstract]   [Full Text] [Related]  

  • 8. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
    Yuan FF; Bryant JA; Fletcher A
    Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
    Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T
    Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of glycosyl-phosphatidylinositol-linked glycoproteins in blood cells from paroxysmal nocturnal haemoglobinuria patients: a flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies.
    Navenot JM; Bernard D; Harousseau JL; Muller JY; Blanchard D
    Leuk Lymphoma; 1996 Mar; 21(1-2):143-51. PubMed ID: 8907282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital Defects in the Expression of the Glycosylphosphatidylinositol-Anchored Complement Regulatory Proteins CD59 and Decay-Accelerating Factor.
    Kinoshita T
    Semin Hematol; 2018 Jul; 55(3):136-140. PubMed ID: 30032750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
    Edberg JC; Salmon JE; Whitlow M; Kimberly RP
    J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of the PNH defect by GPI protein transfer: still an open question.
    Bütikofer P
    Blood; 2000 Mar; 95(5):1876-8. PubMed ID: 10744388
    [No Abstract]   [Full Text] [Related]  

  • 14. [Paroxysmal nocturnal hemoglobinuria (PNH) as a hematopoietic stem cell disorder--long-term support of hematopoiesis by a single stem cell clone in patients with PNH].
    Hirota T
    Rinsho Ketsueki; 2002 Apr; 43(4):215-22. PubMed ID: 12043194
    [No Abstract]   [Full Text] [Related]  

  • 15. Paroxysmal nocturnal hemoglobinuria with myelofibrosis: progression to acute myeloblastic leukemia.
    Nakahata J; Takahashi M; Fuse I; Nakamori Y; Nomoto N; Saitoh H; Tatewaki W; Imanari A; Takeshige T; Koike T
    Leuk Lymphoma; 1993 Dec; 12(1-2):137-42. PubMed ID: 7512853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decay accelerating factor (CD55).
    Nicholson-Weller A
    Curr Top Microbiol Immunol; 1992; 178():7-30. PubMed ID: 1385047
    [No Abstract]   [Full Text] [Related]  

  • 17. Decay-accelerating-factor-deficient erythrocytes during the long-term clinical course of patients with paroxysmal nocturnal hemoglobinuria.
    Mahbub B; Nishimura J; Kitani T; Kitano K
    Acta Haematol; 1995; 93(2-4):91-7. PubMed ID: 7543722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of PIG-A gene in a patient who developed reciprocal translocation of chromosome 12 and paroxysmal nocturnal hemoglobinuria during follow-up of aplastic anemia.
    Nishimura JI; Inoue N; Azenishi Y; Hirota T; Akaogi T; Shibano M; Kawagoe K; Ueda E; Machii T; Takeda J
    Am J Hematol; 1996 Mar; 51(3):229-33. PubMed ID: 8619404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of mannosylglucosaminylinositol phospholipids in normal but not paroxysmal nocturnal hemoglobinuria cells.
    Hirose S; Ravi L; Prince GM; Rosenfeld MG; Silber R; Andresen SW; Hazra SV; Medof ME
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6025-9. PubMed ID: 1378620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features and diagnosis of paroxysmal nocturnal hemoglobinuria: correlates with the deficiency of GPI-anchored membrane proteins].
    Ninomiya H
    Rinsho Ketsueki; 1994 Apr; 35(4):352-7. PubMed ID: 7518013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.